{"id":5374,"date":"2025-01-15T13:14:04","date_gmt":"2025-01-15T18:14:04","guid":{"rendered":"https:\/\/provost.ncsu.edu\/global-one-health-academy\/?page_id=5374"},"modified":"2025-01-15T13:24:31","modified_gmt":"2025-01-15T18:24:31","slug":"antimicrobial-resistance","status":"publish","type":"page","link":"https:\/\/provost.ncsu.edu\/global-one-health-academy\/antimicrobial-resistance\/","title":{"rendered":"Antimicrobial Resistance"},"content":{"rendered":"\n\n\n\n\n

By 2050, it is projected that antimicrobial resistant pathogens will result in the death of 10 million people worldwide \u2013 even more than cancer (8.2 million). The problem is greatly exacerbated by the lack of new antimicrobials to treat these infections, gaps in data exchange, changing climate, the need for rapid diagnostics, and researchers working in silos. NC State has the expertise to overcome these challenges and improve outcomes by targeting AMR at the local, national, and global levels using the One Health lens.<\/p>\n\n\n\n

The Grand Challenges Addressing Program on Antimicrobial Resistance (GCAP-AMR) will catalyze NC State\u2019s tremendous strengths in areas ranging from molecules to population-based approaches, centered around themes including:<\/p>\n\n\n\n